What causes recurrent Diabetic Ketoacidosis (DKA) in a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Recurrent Diabetic Ketoacidosis (DKA)

The most common cause of recurrent DKA is insulin omission, which is frequently associated with psychological problems, financial constraints, and inadequate access to healthcare. 1

Primary Causes of Recurrent DKA

Insulin-Related Factors

  • Insulin omission or non-adherence to insulin therapy is the most common precipitating factor for recurrent DKA 1
  • Economic reasons for stopping insulin, particularly observed in urban African-Americans, are a significant cause of recurrent DKA 1
  • Lack of financial resources or being underinsured contributes significantly to insulin omission 1, 2

Psychosocial Factors

  • Higher incidence of psychiatric illness, especially depression, is observed in patients with recurrent DKA 1, 2
  • Patients with recurrent DKA are more likely to come from single-parent homes 1
  • Eating disorders are more common in adolescents with recurrent episodes of DKA 1
  • Psychological stress can precipitate DKA episodes 3

Medical Factors

  • Intercurrent illnesses, particularly infections (urinary tract infections and pneumonia being most common), account for 30-50% of DKA cases 3
  • Inadequate sick-day management during intercurrent illness 1
  • Surgical procedures, trauma, myocardial ischemia, and pancreatitis can trigger DKA 3
  • Use of sodium-glucose cotransporter-2 (SGLT2) inhibitors can increase the risk of DKA 4, 2

Knowledge and Education Gaps

  • Insufficient patient education about diabetes management 1
  • Lack of knowledge about ketone monitoring during illness 2
  • Inadequate understanding of sick-day management protocols 1
  • Poor communication with healthcare providers during intercurrent illness 1

Clinical Implications and Outcomes

  • Recurrent DKA is associated with significantly greater diabetes morbidity and mortality compared to patients without DKA episodes 1
  • Each DKA episode requires substantial healthcare resources, with an average cost of $13,000 per hospitalization 1
  • Repeated admissions for DKA are estimated to drain approximately one of every two healthcare dollars spent on adult patients with type 1 diabetes 1

Prevention Strategies

  • Regular review of sick-day management with all patients, including when to contact healthcare providers, blood glucose goals, supplemental insulin use during illness, and dietary recommendations 1
  • Emphasize that patients should never discontinue insulin and should seek professional advice early during illness 1
  • Implement 24-hour telephone availability for patients to contact the healthcare team when blood glucose levels are high or ketones are present 2
  • Improve access to medical care and insulin for economically disadvantaged patients 1
  • Provide psychological counseling for all patients with recurrent DKA and their families 1
  • Educate caregivers and family members about signs and symptoms of worsening diabetes control 1
  • Implement public awareness campaigns about signs and symptoms of untreated diabetes 2

Monitoring Recommendations

  • Patients/family members should be able to accurately measure and record blood glucose, urine or blood ketones when blood glucose is >300 mg/dl, insulin administered, vital signs, and body weight 1
  • Ensure adequate supervision and help from staff or family members, particularly for elderly individuals who may be unable to recognize or treat evolving hyperglycemic conditions 1

By addressing these causes systematically through improved access to care, patient education, and psychological support, many recurrent DKA episodes can be prevented, reducing the associated morbidity, mortality, and healthcare costs.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diabetic Ketoacidosis Complications and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetic Ketoacidosis: Evaluation and Treatment.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.